|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/52 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61K 31/167 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/404 | (2006.01) |
| (11) | Number of the document | 3426254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17762648.8 |
| Date of filing the European patent application | 2017-03-09 | |
| (97) | Date of publication of the European application | 2019-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2017/050301 |
| Date | 2017-03-09 |
| (87) | Number | WO 2017/154001 |
| Date | 2017-09-14 |
| (30) | Number | Date | Country code |
| 201662306147 P | 2016-03-10 | US |
| (72) |
SHELACH, Noa , IL
|
| (73) |
Lutris Pharma Ltd. ,
27 Habarzel St., 6971039 Tel Aviv,
IL
|
| (54) | USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS |
| USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS |